

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vascular endothelial growth factor signaling pathway (GO:0038084) | 6.15931681 |
| 2 | lymph vessel development (GO:0001945) | 5.41516625 |
| 3 | lymphangiogenesis (GO:0001946) | 5.30331786 |
| 4 | NADH metabolic process (GO:0006734) | 5.14456620 |
| 5 | chondrocyte proliferation (GO:0035988) | 4.91511865 |
| 6 | endothelial cell morphogenesis (GO:0001886) | 4.69301198 |
| 7 | wound healing, spreading of epidermal cells (GO:0035313) | 4.67403073 |
| 8 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.55791127 |
| 9 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.46943404 |
| 10 | glomerular basement membrane development (GO:0032836) | 4.45950576 |
| 11 | glomerular visceral epithelial cell development (GO:0072015) | 4.43283534 |
| 12 | basement membrane organization (GO:0071711) | 4.30376996 |
| 13 | triglyceride catabolic process (GO:0019433) | 4.21372655 |
| 14 | endothelium development (GO:0003158) | 4.18172687 |
| 15 | collagen fibril organization (GO:0030199) | 4.11967439 |
| 16 | cell adhesion mediated by integrin (GO:0033627) | 4.05379901 |
| 17 | regulation of endothelial cell differentiation (GO:0045601) | 4.04665473 |
| 18 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.99723783 |
| 19 | glomerular epithelial cell development (GO:0072310) | 3.85273923 |
| 20 | plasma membrane repair (GO:0001778) | 3.80643137 |
| 21 | neutral lipid catabolic process (GO:0046461) | 3.80043649 |
| 22 | acylglycerol catabolic process (GO:0046464) | 3.80043649 |
| 23 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.79766418 |
| 24 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.78305014 |
| 25 | axon extension involved in axon guidance (GO:0048846) | 3.78305014 |
| 26 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.77510914 |
| 27 | regulation of tight junction assembly (GO:2000810) | 3.77281207 |
| 28 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.62217453 |
| 29 | wound healing, spreading of cells (GO:0044319) | 3.61962015 |
| 30 | blood vessel endothelial cell migration (GO:0043534) | 3.58055398 |
| 31 | cell migration involved in heart development (GO:0060973) | 3.57039651 |
| 32 | protein heterotrimerization (GO:0070208) | 3.55922030 |
| 33 | biotin metabolic process (GO:0006768) | 3.55420781 |
| 34 | morphogenesis of an endothelium (GO:0003159) | 3.54812722 |
| 35 | endothelial tube morphogenesis (GO:0061154) | 3.54812722 |
| 36 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.54340305 |
| 37 | peptidyl-proline hydroxylation (GO:0019511) | 3.49675789 |
| 38 | blood vessel maturation (GO:0001955) | 3.49349399 |
| 39 | endothelial cell proliferation (GO:0001935) | 3.49181986 |
| 40 | protein targeting to plasma membrane (GO:0072661) | 3.46595481 |
| 41 | renal filtration (GO:0097205) | 3.46205451 |
| 42 | extracellular fibril organization (GO:0043206) | 3.43840254 |
| 43 | sprouting angiogenesis (GO:0002040) | 3.41834953 |
| 44 | cGMP-mediated signaling (GO:0019934) | 3.33760592 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.32597996 |
| 46 | adhesion of symbiont to host (GO:0044406) | 3.32406404 |
| 47 | low-density lipoprotein particle clearance (GO:0034383) | 3.31627832 |
| 48 | positive regulation of vasculogenesis (GO:2001214) | 3.31442160 |
| 49 | glomerular filtration (GO:0003094) | 3.24999912 |
| 50 | endocrine hormone secretion (GO:0060986) | 3.22228904 |
| 51 | surfactant homeostasis (GO:0043129) | 3.21978212 |
| 52 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.19969772 |
| 53 | endodermal cell differentiation (GO:0035987) | 3.19114040 |
| 54 | substrate-dependent cell migration (GO:0006929) | 3.17837989 |
| 55 | positive regulation of endothelial cell migration (GO:0010595) | 3.17033069 |
| 56 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.16439285 |
| 57 | endothelial cell differentiation (GO:0045446) | 3.14874318 |
| 58 | ethanol oxidation (GO:0006069) | 3.13713485 |
| 59 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.13694663 |
| 60 | regulation of sequestering of triglyceride (GO:0010889) | 3.12889210 |
| 61 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.11634535 |
| 62 | cellular response to interferon-alpha (GO:0035457) | 3.10362373 |
| 63 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.10028095 |
| 64 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.07400822 |
| 65 | regulation of metalloenzyme activity (GO:0048552) | 3.03584702 |
| 66 | extracellular matrix assembly (GO:0085029) | 3.03295139 |
| 67 | epithelial cell-cell adhesion (GO:0090136) | 2.94884787 |
| 68 | protein hydroxylation (GO:0018126) | 2.93292800 |
| 69 | ganglion development (GO:0061548) | 2.92475411 |
| 70 | regulation of vasculogenesis (GO:2001212) | 2.90216976 |
| 71 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.89695574 |
| 72 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.89478689 |
| 73 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.86737319 |
| 74 | regulation of lipoprotein metabolic process (GO:0050746) | 2.86117444 |
| 75 | short-chain fatty acid metabolic process (GO:0046459) | 2.86045588 |
| 76 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.84166446 |
| 77 | apoptotic cell clearance (GO:0043277) | 2.84003326 |
| 78 | atrioventricular valve morphogenesis (GO:0003181) | 2.83932412 |
| 79 | lung lobe morphogenesis (GO:0060463) | 2.80464406 |
| 80 | alpha-linolenic acid metabolic process (GO:0036109) | 2.79524477 |
| 81 | alditol metabolic process (GO:0019400) | 2.79512786 |
| 82 | fatty acid beta-oxidation (GO:0006635) | 2.79051237 |
| 83 | fructose metabolic process (GO:0006000) | 2.78447827 |
| 84 | fatty acid transmembrane transport (GO:1902001) | 2.77333646 |
| 85 | type B pancreatic cell proliferation (GO:0044342) | 2.77295971 |
| 86 | carnitine shuttle (GO:0006853) | 2.76889323 |
| 87 | regulation of receptor binding (GO:1900120) | 2.76725857 |
| 88 | positive regulation of epithelial cell migration (GO:0010634) | 2.76207599 |
| 89 | glycerolipid catabolic process (GO:0046503) | 2.73874667 |
| 90 | protein localization to cell surface (GO:0034394) | 2.73528649 |
| 91 | fibril organization (GO:0097435) | 2.73351822 |
| 92 | positive regulation of collagen biosynthetic process (GO:0032967) | 2.73309570 |
| 93 | blood vessel remodeling (GO:0001974) | 2.72428336 |
| 94 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.72337428 |
| 95 | collagen metabolic process (GO:0032963) | 2.72159157 |
| 96 | artery development (GO:0060840) | 2.70543812 |
| 97 | desmosome organization (GO:0002934) | 2.69842246 |
| 98 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.69428911 |
| 99 | fatty acid catabolic process (GO:0009062) | 2.68916524 |
| 100 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.68566994 |
| 101 | regulation of macrophage chemotaxis (GO:0010758) | 2.66506683 |
| 102 | keratan sulfate catabolic process (GO:0042340) | 2.66137154 |
| 103 | endothelial cell migration (GO:0043542) | 2.64837993 |
| 104 | endothelial cell chemotaxis (GO:0035767) | 2.64810021 |
| 105 | lung vasculature development (GO:0060426) | 2.63371201 |
| 106 | heart trabecula formation (GO:0060347) | 2.62862682 |
| 107 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.62034315 |
| 108 | protein retention in ER lumen (GO:0006621) | 2.61910234 |
| 109 | complement activation, classical pathway (GO:0006958) | 2.61578349 |
| 110 | negative regulation of platelet activation (GO:0010544) | 2.61344873 |
| 111 | adhesion of symbiont to host cell (GO:0044650) | 2.61119684 |
| 112 | virion attachment to host cell (GO:0019062) | 2.61119684 |
| 113 | positive regulation of collagen metabolic process (GO:0010714) | 2.58919987 |
| 114 | regulation of endothelial cell migration (GO:0010594) | 2.58856669 |
| 115 | nitric oxide biosynthetic process (GO:0006809) | 2.58840595 |
| 116 | collagen catabolic process (GO:0030574) | 2.56373725 |
| 117 | primary alcohol metabolic process (GO:0034308) | 2.55872928 |
| 118 | multicellular organismal metabolic process (GO:0044236) | 2.55396689 |
| 119 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.54842045 |
| 120 | smooth muscle tissue development (GO:0048745) | 2.54206170 |
| 121 | response to dietary excess (GO:0002021) | 2.54168987 |
| 122 | regulation of blood vessel endothelial cell migration (GO:0043535) | 2.54014319 |
| 123 | multicellular organismal catabolic process (GO:0044243) | 2.53388195 |
| 124 | regulation of plasminogen activation (GO:0010755) | 2.53336788 |
| 125 | skin morphogenesis (GO:0043589) | 2.53008532 |
| 126 | extracellular matrix disassembly (GO:0022617) | 2.52941721 |
| 127 | negative regulation of endothelial cell migration (GO:0010596) | 2.51893886 |
| 128 | angiotensin maturation (GO:0002003) | 2.51064174 |
| 129 | negative regulation of endothelial cell proliferation (GO:0001937) | 2.50660205 |
| 130 | positive regulation of extracellular matrix organization (GO:1903055) | 2.50218205 |
| 131 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.50118937 |
| 132 | fatty acid oxidation (GO:0019395) | 2.49471161 |
| 133 | acylglycerol homeostasis (GO:0055090) | 2.49173502 |
| 134 | triglyceride homeostasis (GO:0070328) | 2.49173502 |
| 135 | cellular response to lithium ion (GO:0071285) | 2.47443743 |
| 136 | positive regulation of epithelial to mesenchymal transition (GO:0010718) | 2.47348711 |
| 137 | regulation of glomerular filtration (GO:0003093) | 2.47190792 |
| 138 | glycerol metabolic process (GO:0006071) | 2.46945769 |
| 139 | transcytosis (GO:0045056) | 2.46476604 |
| 140 | actin filament depolymerization (GO:0030042) | 2.46437710 |
| 141 | extracellular matrix organization (GO:0030198) | 2.46404746 |
| 142 | venous blood vessel morphogenesis (GO:0048845) | 2.46252693 |
| 143 | extracellular structure organization (GO:0043062) | 2.45843879 |
| 144 | monocarboxylic acid catabolic process (GO:0072329) | 2.44872643 |
| 145 | ethanol metabolic process (GO:0006067) | 2.44871865 |
| 146 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.43930104 |
| 147 | fatty acid homeostasis (GO:0055089) | 2.43556314 |
| 148 | lipid oxidation (GO:0034440) | 2.43217364 |
| 149 | complement activation (GO:0006956) | 2.43134532 |
| 150 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.43014934 |
| 151 | regulation of mononuclear cell migration (GO:0071675) | 2.42934382 |
| 152 | diacylglycerol metabolic process (GO:0046339) | 2.40599947 |
| 153 | triglyceride biosynthetic process (GO:0019432) | 2.40509097 |
| 154 | oxaloacetate metabolic process (GO:0006107) | 2.38597215 |
| 155 | branching involved in prostate gland morphogenesis (GO:0060442) | 2.38372674 |
| 156 | tricarboxylic acid metabolic process (GO:0072350) | 2.34812262 |
| 157 | complement activation, alternative pathway (GO:0006957) | 2.33830217 |
| 158 | acylglycerol biosynthetic process (GO:0046463) | 2.32791277 |
| 159 | neutral lipid biosynthetic process (GO:0046460) | 2.32791277 |
| 160 | negative regulation of protein localization to cell surface (GO:2000009) | 2.31990333 |
| 161 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 2.30786077 |
| 162 | phenol-containing compound catabolic process (GO:0019336) | 2.29641837 |
| 163 | 4-hydroxyproline metabolic process (GO:0019471) | 2.25668772 |
| 164 | barbed-end actin filament capping (GO:0051016) | 2.25239811 |
| 165 | polyol transport (GO:0015791) | 2.25091917 |
| 166 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.24301674 |
| 167 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.24301674 |
| 168 | cellular response to cadmium ion (GO:0071276) | 2.22921738 |
| 169 | bile acid metabolic process (GO:0008206) | 2.22858595 |
| 170 | negative regulation of catenin import into nucleus (GO:0035414) | 2.21999254 |
| 171 | creatine metabolic process (GO:0006600) | 2.21778520 |
| 172 | epoxygenase P450 pathway (GO:0019373) | 2.21753910 |
| 173 | positive regulation of astrocyte differentiation (GO:0048711) | 2.21184149 |
| 174 | triglyceride metabolic process (GO:0006641) | 2.20372240 |
| 175 | L-serine transport (GO:0015825) | 2.20010551 |
| 176 | positive regulation of glycolytic process (GO:0045821) | 2.17524379 |
| 177 | ovulation from ovarian follicle (GO:0001542) | 2.16614525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 7.47848859 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.67369790 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 5.35413930 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.56233599 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.49859516 |
| 6 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 3.10192748 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.00991699 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.93319836 |
| 9 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.90096663 |
| 10 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.77371873 |
| 11 | CJUN_26792858_Chip-Seq_BT549_Human | 2.65336659 |
| 12 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.55412882 |
| 13 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.55304163 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.47212181 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.45625416 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.40836297 |
| 17 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32093354 |
| 18 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.25078411 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.16019580 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14896456 |
| 21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.12551754 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.08467808 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.05796011 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.05340845 |
| 25 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.03852564 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.02153051 |
| 27 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 2.02140846 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.01282162 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.00136912 |
| 30 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.96167986 |
| 31 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.87889741 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.83841343 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81303048 |
| 34 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79234708 |
| 35 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.73848593 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.73101992 |
| 37 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.73101992 |
| 38 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72033997 |
| 39 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69936744 |
| 40 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.63617910 |
| 41 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.60927085 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60658658 |
| 43 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.58833142 |
| 44 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.58433088 |
| 45 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.58433088 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56420103 |
| 47 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.52917240 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.50036280 |
| 49 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.47508947 |
| 50 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.46321109 |
| 51 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42869475 |
| 52 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.40156357 |
| 53 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.40156357 |
| 54 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35969589 |
| 55 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33966043 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27520854 |
| 57 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26425576 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26074427 |
| 59 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.25899404 |
| 60 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.25884060 |
| 61 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25183262 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24793876 |
| 63 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23707625 |
| 64 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20906103 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20754574 |
| 66 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.20343786 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.18736069 |
| 68 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14678641 |
| 69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13977732 |
| 70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13971813 |
| 71 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11872886 |
| 72 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.11598282 |
| 73 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.10877431 |
| 74 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.10256364 |
| 75 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.10256364 |
| 76 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.10256364 |
| 77 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.09865996 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08506925 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08408036 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07663052 |
| 81 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.07562141 |
| 82 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07076226 |
| 83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06949274 |
| 84 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.06292390 |
| 85 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.05392790 |
| 86 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.04029870 |
| 87 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.03720669 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.03142244 |
| 89 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.02701755 |
| 90 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02590925 |
| 91 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.00511953 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99189623 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98998815 |
| 94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98864067 |
| 95 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98235030 |
| 96 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.97886786 |
| 97 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.97075248 |
| 98 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95994158 |
| 99 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.95706458 |
| 100 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94732815 |
| 101 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94539274 |
| 102 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93612568 |
| 103 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93106335 |
| 104 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.92920660 |
| 105 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.92609507 |
| 106 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92211639 |
| 107 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90516568 |
| 108 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.89561274 |
| 109 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88625727 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88454433 |
| 111 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.88427742 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88161530 |
| 113 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87988267 |
| 114 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86542824 |
| 115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.86207954 |
| 116 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85708942 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85698419 |
| 118 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85427911 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85425090 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85368085 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84788738 |
| 122 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.84763154 |
| 123 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84268787 |
| 124 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.83917667 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83736742 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.83510440 |
| 127 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.83402757 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82421581 |
| 129 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.81464679 |
| 130 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.80428182 |
| 131 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80140205 |
| 132 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.80000908 |
| 133 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.79893454 |
| 134 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.78291720 |
| 135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.77764282 |
| 136 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75036972 |
| 137 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74744403 |
| 138 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74595096 |
| 139 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.74455087 |
| 140 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74354780 |
| 141 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.73977602 |
| 142 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.73977602 |
| 143 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.73353718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.61485329 |
| 2 | MP0010368_abnormal_lymphatic_system | 4.81214951 |
| 3 | MP0004272_abnormal_basement_membrane | 4.46330473 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.12689947 |
| 5 | MP0005275_abnormal_skin_tensile | 3.96856408 |
| 6 | MP0001879_abnormal_lymphatic_vessel | 3.93187226 |
| 7 | MP0003279_aneurysm | 3.72986087 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.44155975 |
| 9 | MP0006054_spinal_hemorrhage | 2.93588706 |
| 10 | MP0005666_abnormal_adipose_tissue | 2.60955706 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.58031476 |
| 12 | MP0005360_urolithiasis | 2.56261088 |
| 13 | MP0000013_abnormal_adipose_tissue | 2.56131097 |
| 14 | MP0005623_abnormal_meninges_morphology | 2.55896317 |
| 15 | MP0001958_emphysema | 2.55462974 |
| 16 | MP0003011_delayed_dark_adaptation | 2.50302224 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.32091761 |
| 18 | MP0002295_abnormal_pulmonary_circulatio | 2.29204124 |
| 19 | MP0003566_abnormal_cell_adhesion | 2.28510776 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 2.23929508 |
| 21 | MP0005375_adipose_tissue_phenotype | 2.00209913 |
| 22 | MP0002971_abnormal_brown_adipose | 1.97769417 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 1.93761172 |
| 24 | MP0009384_cardiac_valve_regurgitation | 1.88413559 |
| 25 | MP0001542_abnormal_bone_strength | 1.84083516 |
| 26 | MP0000749_muscle_degeneration | 1.77407496 |
| 27 | MP0000751_myopathy | 1.73934634 |
| 28 | MP0000750_abnormal_muscle_regeneration | 1.73894423 |
| 29 | MP0005023_abnormal_wound_healing | 1.71338741 |
| 30 | MP0003724_increased_susceptibility_to | 1.70702881 |
| 31 | MP0000767_abnormal_smooth_muscle | 1.69982016 |
| 32 | MP0003868_abnormal_feces_composition | 1.68856734 |
| 33 | MP0008004_abnormal_stomach_pH | 1.66249886 |
| 34 | MP0003091_abnormal_cell_migration | 1.64371493 |
| 35 | MP0005508_abnormal_skeleton_morphology | 1.63447534 |
| 36 | MP0003828_pulmonary_edema | 1.62182538 |
| 37 | MP0006138_congestive_heart_failure | 1.60725725 |
| 38 | MP0008775_abnormal_heart_ventricle | 1.56830522 |
| 39 | MP0004130_abnormal_muscle_cell | 1.55468877 |
| 40 | MP0004145_abnormal_muscle_electrophysio | 1.55120080 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.53848393 |
| 42 | MP0005365_abnormal_bile_salt | 1.52073442 |
| 43 | MP0004036_abnormal_muscle_relaxation | 1.49494659 |
| 44 | MP0010030_abnormal_orbit_morphology | 1.46371617 |
| 45 | MP0000343_altered_response_to | 1.39432214 |
| 46 | MP0005595_abnormal_vascular_smooth | 1.38990296 |
| 47 | MP0005085_abnormal_gallbladder_physiolo | 1.35261355 |
| 48 | MP0003941_abnormal_skin_development | 1.29970431 |
| 49 | MP0003959_abnormal_lean_body | 1.29819896 |
| 50 | MP0002139_abnormal_hepatobiliary_system | 1.27000968 |
| 51 | MP0002108_abnormal_muscle_morphology | 1.25441500 |
| 52 | MP0009840_abnormal_foam_cell | 1.25414262 |
| 53 | MP0004484_altered_response_of | 1.24475783 |
| 54 | MP0005620_abnormal_muscle_contractility | 1.22109284 |
| 55 | MP0005164_abnormal_response_to | 1.21691481 |
| 56 | MP0002972_abnormal_cardiac_muscle | 1.19968996 |
| 57 | MP0005330_cardiomyopathy | 1.17598989 |
| 58 | MP0005385_cardiovascular_system_phenoty | 1.17157525 |
| 59 | MP0001544_abnormal_cardiovascular_syste | 1.17157525 |
| 60 | MP0004185_abnormal_adipocyte_glucose | 1.15135519 |
| 61 | MP0002128_abnormal_blood_circulation | 1.12856088 |
| 62 | MP0005165_increased_susceptibility_to | 1.12575768 |
| 63 | MP0001661_extended_life_span | 1.10386957 |
| 64 | MP0009250_abnormal_appendicular_skeleto | 1.09814651 |
| 65 | MP0001614_abnormal_blood_vessel | 1.08905658 |
| 66 | MP0000230_abnormal_systemic_arterial | 1.08396514 |
| 67 | MP0000534_abnormal_ureter_morphology | 1.08029713 |
| 68 | MP0002896_abnormal_bone_mineralization | 1.07764535 |
| 69 | MP0001243_abnormal_dermal_layer | 1.06884304 |
| 70 | MP0009780_abnormal_chondrocyte_physiolo | 1.05813521 |
| 71 | MP0009115_abnormal_fat_cell | 1.05794400 |
| 72 | MP0009379_abnormal_foot_pigmentation | 1.04782104 |
| 73 | MP0000249_abnormal_blood_vessel | 1.04683257 |
| 74 | MP0001756_abnormal_urination | 1.04082614 |
| 75 | MP0001666_abnormal_nutrient_absorption | 1.03629692 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.03105893 |
| 77 | MP0004019_abnormal_vitamin_homeostasis | 1.02658391 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 1.00156902 |
| 79 | MP0005332_abnormal_amino_acid | 0.99801084 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.99568678 |
| 81 | MP0002282_abnormal_trachea_morphology | 0.98967857 |
| 82 | MP0003385_abnormal_body_wall | 0.98247022 |
| 83 | MP0004087_abnormal_muscle_fiber | 0.97908473 |
| 84 | MP0005390_skeleton_phenotype | 0.97790697 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 0.96917868 |
| 86 | MP0003950_abnormal_plasma_membrane | 0.96712778 |
| 87 | MP0003879_abnormal_hair_cell | 0.96684601 |
| 88 | MP0002060_abnormal_skin_morphology | 0.95592314 |
| 89 | MP0001188_hyperpigmentation | 0.92662989 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.91638118 |
| 91 | MP0002127_abnormal_cardiovascular_syste | 0.91098106 |
| 92 | MP0005670_abnormal_white_adipose | 0.90379166 |
| 93 | MP0005334_abnormal_fat_pad | 0.89178295 |
| 94 | MP0002168_other_aberrant_phenotype | 0.87314102 |
| 95 | MP0003045_fibrosis | 0.86580171 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.86549382 |
| 97 | MP0003942_abnormal_urinary_system | 0.85293815 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.83925295 |
| 99 | MP0002925_abnormal_cardiovascular_devel | 0.83833169 |
| 100 | MP0002269_muscular_atrophy | 0.83609056 |
| 101 | MP0002970_abnormal_white_adipose | 0.83478238 |
| 102 | MP0000462_abnormal_digestive_system | 0.83257886 |
| 103 | MP0000759_abnormal_skeletal_muscle | 0.83047036 |
| 104 | MP0005257_abnormal_intraocular_pressure | 0.82155799 |
| 105 | MP0000163_abnormal_cartilage_morphology | 0.80459985 |
| 106 | MP0003646_muscle_fatigue | 0.80265780 |
| 107 | MP0004858_abnormal_nervous_system | 0.79871266 |
| 108 | MP0005409_darkened_coat_color | 0.79853096 |
| 109 | MP0003806_abnormal_nucleotide_metabolis | 0.77348349 |
| 110 | MP0001881_abnormal_mammary_gland | 0.77255480 |
| 111 | MP0003690_abnormal_glial_cell | 0.77093754 |
| 112 | MP0010630_abnormal_cardiac_muscle | 0.76833877 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.76752964 |
| 114 | MP0005647_abnormal_sex_gland | 0.76334844 |
| 115 | MP0005535_abnormal_body_temperature | 0.75458081 |
| 116 | MP0000747_muscle_weakness | 0.75432619 |
| 117 | MP0000733_abnormal_muscle_development | 0.75283040 |
| 118 | MP0002115_abnormal_skeleton_extremities | 0.74696726 |
| 119 | MP0001533_abnormal_skeleton_physiology | 0.74007099 |
| 120 | MP0005369_muscle_phenotype | 0.73529698 |
| 121 | MP0005388_respiratory_system_phenotype | 0.73473160 |
| 122 | MP0002133_abnormal_respiratory_system | 0.73473160 |
| 123 | MP0004883_abnormal_blood_vessel | 0.72257870 |
| 124 | MP0001764_abnormal_homeostasis | 0.71438987 |
| 125 | MP0004134_abnormal_chest_morphology | 0.70474341 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.68804815 |
| 127 | MP0000266_abnormal_heart_morphology | 0.68545792 |
| 128 | MP0003137_abnormal_impulse_conducting | 0.67303832 |
| 129 | MP0001299_abnormal_eye_distance/ | 0.67106469 |
| 130 | MP0002933_joint_inflammation | 0.67066963 |
| 131 | MP0004233_abnormal_muscle_weight | 0.66710806 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.64685168 |
| 133 | MP0000516_abnormal_urinary_system | 0.64685168 |
| 134 | MP0005171_absent_coat_pigmentation | 0.64547353 |
| 135 | MP0006276_abnormal_autonomic_nervous | 0.63894850 |
| 136 | MP0003186_abnormal_redox_activity | 0.62800813 |
| 137 | MP0002106_abnormal_muscle_physiology | 0.62100532 |
| 138 | MP0000538_abnormal_urinary_bladder | 0.61603840 |
| 139 | MP0000537_abnormal_urethra_morphology | 0.61031498 |
| 140 | MP0005379_endocrine/exocrine_gland_phen | 0.58672318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 6.69910536 |
| 2 | Protrusio acetabuli (HP:0003179) | 6.67263099 |
| 3 | Aortic dissection (HP:0002647) | 4.68144235 |
| 4 | Aortic aneurysm (HP:0004942) | 4.66311324 |
| 5 | Complement deficiency (HP:0004431) | 4.12569504 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.91851315 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.85419465 |
| 8 | Increased connective tissue (HP:0009025) | 3.82055410 |
| 9 | Soft skin (HP:0000977) | 3.73666140 |
| 10 | Muscle fiber splitting (HP:0003555) | 3.61443378 |
| 11 | Abnormality of complement system (HP:0005339) | 3.58793307 |
| 12 | Spinal rigidity (HP:0003306) | 3.54466547 |
| 13 | Nonimmune hydrops fetalis (HP:0001790) | 3.50394303 |
| 14 | Wrist flexion contracture (HP:0001239) | 3.48686806 |
| 15 | Atrophic scars (HP:0001075) | 3.43338251 |
| 16 | Abnormality of dentin (HP:0010299) | 3.39631929 |
| 17 | Type 1 muscle fiber predominance (HP:0003803) | 3.39443257 |
| 18 | Peritonitis (HP:0002586) | 3.35547981 |
| 19 | Dilatation of the ascending aorta (HP:0005111) | 3.33753378 |
| 20 | Broad metatarsal (HP:0001783) | 3.27404177 |
| 21 | Vascular tortuosity (HP:0004948) | 3.24111482 |
| 22 | Polycythemia (HP:0001901) | 3.22151289 |
| 23 | Ankle contracture (HP:0006466) | 3.14197316 |
| 24 | Difficulty climbing stairs (HP:0003551) | 3.12909476 |
| 25 | Vertebral compression fractures (HP:0002953) | 3.12793838 |
| 26 | Cervical subluxation (HP:0003308) | 3.06553903 |
| 27 | Fragile skin (HP:0001030) | 3.05878495 |
| 28 | Shallow orbits (HP:0000586) | 2.96999997 |
| 29 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.92579322 |
| 30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.86352507 |
| 31 | Oligomenorrhea (HP:0000876) | 2.85217337 |
| 32 | Wormian bones (HP:0002645) | 2.80637565 |
| 33 | Hyporeflexia of lower limbs (HP:0002600) | 2.78428757 |
| 34 | Round ear (HP:0100830) | 2.75488779 |
| 35 | Hydroxyprolinuria (HP:0003080) | 2.74160998 |
| 36 | Abnormality of proline metabolism (HP:0010907) | 2.74160998 |
| 37 | Hematochezia (HP:0002573) | 2.72565474 |
| 38 | Short nail (HP:0001799) | 2.69884024 |
| 39 | Distal arthrogryposis (HP:0005684) | 2.66096036 |
| 40 | Arterial tortuosity (HP:0005116) | 2.64817863 |
| 41 | Bladder diverticulum (HP:0000015) | 2.63294631 |
| 42 | Overgrowth (HP:0001548) | 2.60128310 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.58975038 |
| 44 | Right ventricular cardiomyopathy (HP:0011663) | 2.52549023 |
| 45 | Aneurysm (HP:0002617) | 2.51316436 |
| 46 | Increased variability in muscle fiber diameter (HP:0003557) | 2.50344011 |
| 47 | Intrahepatic cholestasis (HP:0001406) | 2.49659369 |
| 48 | Acanthosis nigricans (HP:0000956) | 2.46499817 |
| 49 | Mesangial abnormality (HP:0001966) | 2.45698770 |
| 50 | Blue sclerae (HP:0000592) | 2.45538840 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.41642559 |
| 52 | Hyperglycinuria (HP:0003108) | 2.41258500 |
| 53 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.37379803 |
| 54 | Coronal craniosynostosis (HP:0004440) | 2.35062295 |
| 55 | Abnormality of the nasal mucosa (HP:0000433) | 2.32877680 |
| 56 | Glomerulonephritis (HP:0000099) | 2.32445521 |
| 57 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.30734692 |
| 58 | Genu recurvatum (HP:0002816) | 2.29038788 |
| 59 | Biconcave vertebral bodies (HP:0004586) | 2.28459670 |
| 60 | Absent phalangeal crease (HP:0006109) | 2.25978341 |
| 61 | Muscle fiber inclusion bodies (HP:0100299) | 2.25838766 |
| 62 | Abnormal delivery (HP:0001787) | 2.25778321 |
| 63 | Asymmetric septal hypertrophy (HP:0001670) | 2.22697752 |
| 64 | Venous abnormality (HP:0002624) | 2.21915911 |
| 65 | Abnormality of the acetabulum (HP:0003170) | 2.21831549 |
| 66 | Knee flexion contracture (HP:0006380) | 2.20305067 |
| 67 | Coxa vara (HP:0002812) | 2.20109497 |
| 68 | Abnormality of glycine metabolism (HP:0010895) | 2.19718692 |
| 69 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.19718692 |
| 70 | Mitral valve prolapse (HP:0001634) | 2.19462727 |
| 71 | Neonatal short-limb short stature (HP:0008921) | 2.18723409 |
| 72 | Cupped ribs (HP:0000887) | 2.18034340 |
| 73 | Growth hormone excess (HP:0000845) | 2.17924761 |
| 74 | Follicular hyperkeratosis (HP:0007502) | 2.17048154 |
| 75 | Abnormality of the calf musculature (HP:0001430) | 2.16129184 |
| 76 | Chondrocalcinosis (HP:0000934) | 2.13962713 |
| 77 | Exercise-induced myalgia (HP:0003738) | 2.13292918 |
| 78 | Neck muscle weakness (HP:0000467) | 2.12836269 |
| 79 | Rhabdomyolysis (HP:0003201) | 2.11811919 |
| 80 | Bundle branch block (HP:0011710) | 2.11205448 |
| 81 | Nemaline bodies (HP:0003798) | 2.11139485 |
| 82 | Calcaneovalgus deformity (HP:0001848) | 2.10333485 |
| 83 | Aortic regurgitation (HP:0001659) | 2.10205059 |
| 84 | Abnormality of carpal bone ossification (HP:0006257) | 2.08934598 |
| 85 | Hyperextensible skin (HP:0000974) | 2.08152983 |
| 86 | Hyperlipoproteinemia (HP:0010980) | 2.07616454 |
| 87 | Camptodactyly of toe (HP:0001836) | 2.05510293 |
| 88 | Calf muscle hypertrophy (HP:0008981) | 2.05394349 |
| 89 | Myoglobinuria (HP:0002913) | 2.05149914 |
| 90 | Venous insufficiency (HP:0005293) | 2.04273873 |
| 91 | EMG: myopathic abnormalities (HP:0003458) | 2.04036275 |
| 92 | Nephritis (HP:0000123) | 2.03984239 |
| 93 | Cerebral palsy (HP:0100021) | 2.03556791 |
| 94 | Short hallux (HP:0010109) | 2.03326781 |
| 95 | Bulbar palsy (HP:0001283) | 2.02700195 |
| 96 | Ulnar deviation of the wrist (HP:0003049) | 2.00335124 |
| 97 | Hip contracture (HP:0003273) | 2.00297179 |
| 98 | Focal segmental glomerulosclerosis (HP:0000097) | 2.00279345 |
| 99 | Deformed tarsal bones (HP:0008119) | 2.00232356 |
| 100 | Abnormality of Sharpey fibers (HP:0100685) | 1.98277775 |
| 101 | Osteolytic defects of the hand bones (HP:0009699) | 1.96882264 |
| 102 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.96882264 |
| 103 | Conjugated hyperbilirubinemia (HP:0002908) | 1.96688723 |
| 104 | Elbow flexion contracture (HP:0002987) | 1.96073144 |
| 105 | Ileus (HP:0002595) | 1.95057906 |
| 106 | Sudden death (HP:0001699) | 1.94069535 |
| 107 | Conjunctival telangiectasia (HP:0000524) | 1.94040164 |
| 108 | Ectopia lentis (HP:0001083) | 1.93094327 |
| 109 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.90640681 |
| 110 | Platyspondyly (HP:0000926) | 1.90365715 |
| 111 | Cardiovascular calcification (HP:0011915) | 1.88269897 |
| 112 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.88121292 |
| 113 | Abnormal atrioventricular conduction (HP:0005150) | 1.86821533 |
| 114 | Pulmonary artery stenosis (HP:0004415) | 1.86651215 |
| 115 | Joint laxity (HP:0001388) | 1.86094179 |
| 116 | Hypoplastic ischia (HP:0003175) | 1.85976907 |
| 117 | Osteoarthritis (HP:0002758) | 1.85880551 |
| 118 | Scapular winging (HP:0003691) | 1.85858075 |
| 119 | Esophageal varix (HP:0002040) | 1.83714246 |
| 120 | Increased serum pyruvate (HP:0003542) | 1.83592471 |
| 121 | Joint stiffness (HP:0001387) | 1.83457285 |
| 122 | Muscle fibrillation (HP:0010546) | 1.82953492 |
| 123 | Xanthomatosis (HP:0000991) | 1.81464597 |
| 124 | Heart block (HP:0012722) | 1.81137724 |
| 125 | Back pain (HP:0003418) | 1.80558612 |
| 126 | Myopathic facies (HP:0002058) | 1.79033670 |
| 127 | Abnormal finger flexion creases (HP:0006143) | 1.78970539 |
| 128 | Malnutrition (HP:0004395) | 1.78605742 |
| 129 | Wide anterior fontanel (HP:0000260) | 1.78201821 |
| 130 | Lipoatrophy (HP:0100578) | 1.77814144 |
| 131 | Fat malabsorption (HP:0002630) | 1.77661770 |
| 132 | Gowers sign (HP:0003391) | 1.77597192 |
| 133 | Redundant skin (HP:0001582) | 1.77555736 |
| 134 | Choanal stenosis (HP:0000452) | 1.77252983 |
| 135 | Hypertriglyceridemia (HP:0002155) | 1.77241922 |
| 136 | Lymphangioma (HP:0100764) | 1.76580276 |
| 137 | Hemorrhage of the eye (HP:0011885) | 1.76037424 |
| 138 | Skin nodule (HP:0200036) | 1.76001810 |
| 139 | Limited hip movement (HP:0008800) | 1.75899810 |
| 140 | Abnormality of the calcaneus (HP:0008364) | 1.75896138 |
| 141 | Abnormality of the ischium (HP:0003174) | 1.75293507 |
| 142 | Decreased circulating renin level (HP:0003351) | 1.75193595 |
| 143 | Aortic valve stenosis (HP:0001650) | 1.74390702 |
| 144 | Osteopenia (HP:0000938) | 1.72034473 |
| 145 | Areflexia of lower limbs (HP:0002522) | 1.71831202 |
| 146 | Abnormality of glycolysis (HP:0004366) | 1.71028558 |
| 147 | Muscular dystrophy (HP:0003560) | 1.70586268 |
| 148 | Difficulty running (HP:0009046) | 1.70497950 |
| 149 | Mitral stenosis (HP:0001718) | 1.70092926 |
| 150 | Hyperactive renin-angiotensin system (HP:0000841) | 1.70021770 |
| 151 | Ventricular tachycardia (HP:0004756) | 1.69737627 |
| 152 | Mitral regurgitation (HP:0001653) | 1.69598403 |
| 153 | Renal tubular acidosis (HP:0001947) | 1.69004482 |
| 154 | Turricephaly (HP:0000262) | 1.67555687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.84617845 |
| 2 | KDR | 5.81621774 |
| 3 | PDK2 | 3.22400626 |
| 4 | RIPK1 | 2.87217854 |
| 5 | LATS2 | 2.85430921 |
| 6 | TESK1 | 2.79241188 |
| 7 | TGFBR2 | 2.72429051 |
| 8 | MYLK | 2.62595682 |
| 9 | EPHB2 | 2.47751352 |
| 10 | TTN | 2.45422311 |
| 11 | PIK3CA | 2.22153523 |
| 12 | DDR2 | 2.03392024 |
| 13 | PDK4 | 1.98868743 |
| 14 | PDK3 | 1.98868743 |
| 15 | ERN1 | 1.96969295 |
| 16 | PTK2B | 1.94104790 |
| 17 | WNK4 | 1.91182730 |
| 18 | TGFBR1 | 1.88884767 |
| 19 | LIMK1 | 1.88661495 |
| 20 | CAMK1D | 1.85875771 |
| 21 | AKT3 | 1.82807296 |
| 22 | FER | 1.71397900 |
| 23 | TRIB3 | 1.54239671 |
| 24 | STK38L | 1.53704660 |
| 25 | PRKD2 | 1.53503215 |
| 26 | CAMK1G | 1.51032272 |
| 27 | EEF2K | 1.49877648 |
| 28 | MAP3K3 | 1.45618349 |
| 29 | PDGFRA | 1.44297393 |
| 30 | MAPKAPK3 | 1.35772845 |
| 31 | FRK | 1.35064350 |
| 32 | PIK3CG | 1.31838866 |
| 33 | LATS1 | 1.27659507 |
| 34 | PRKAA2 | 1.26462905 |
| 35 | PIM2 | 1.26195128 |
| 36 | PAK2 | 1.23318236 |
| 37 | CAMK1 | 1.14587888 |
| 38 | PTK2 | 1.12569004 |
| 39 | MAP2K3 | 1.09655093 |
| 40 | STK39 | 1.09298830 |
| 41 | MAP2K1 | 1.07962305 |
| 42 | MAP3K11 | 1.05861900 |
| 43 | MOS | 1.01805974 |
| 44 | SIK1 | 1.01730722 |
| 45 | GRK5 | 1.00784658 |
| 46 | EPHA2 | 1.00062886 |
| 47 | MAP2K6 | 0.97900750 |
| 48 | TRPM7 | 0.94474274 |
| 49 | ZAK | 0.94115799 |
| 50 | PAK4 | 0.92431851 |
| 51 | MAP3K12 | 0.89419558 |
| 52 | TNK2 | 0.88043566 |
| 53 | NME2 | 0.87804035 |
| 54 | PAK3 | 0.87613843 |
| 55 | ROCK1 | 0.87156716 |
| 56 | EPHA3 | 0.86222568 |
| 57 | PRKG2 | 0.83694383 |
| 58 | TESK2 | 0.83289199 |
| 59 | MARK1 | 0.83062407 |
| 60 | NTRK1 | 0.82980341 |
| 61 | ERBB3 | 0.81245566 |
| 62 | SGK494 | 0.79824528 |
| 63 | SGK223 | 0.79824528 |
| 64 | CDC42BPA | 0.77967120 |
| 65 | TAOK2 | 0.76941464 |
| 66 | MAPK12 | 0.75546736 |
| 67 | OBSCN | 0.75389640 |
| 68 | ARAF | 0.75347893 |
| 69 | CAMK2G | 0.74764028 |
| 70 | OXSR1 | 0.71524246 |
| 71 | ABL2 | 0.71478664 |
| 72 | PRKAA1 | 0.71007610 |
| 73 | MET | 0.70885055 |
| 74 | PDGFRB | 0.70692454 |
| 75 | NLK | 0.69465723 |
| 76 | LRRK2 | 0.68734985 |
| 77 | STK38 | 0.66526813 |
| 78 | LMTK2 | 0.65332807 |
| 79 | EPHB1 | 0.65087741 |
| 80 | CAMK2D | 0.64915342 |
| 81 | MAP3K6 | 0.64486555 |
| 82 | NEK9 | 0.63911141 |
| 83 | CASK | 0.60971319 |
| 84 | PRKCE | 0.59346237 |
| 85 | NME1 | 0.58368188 |
| 86 | PRKACG | 0.57706588 |
| 87 | PBK | 0.56030417 |
| 88 | STK10 | 0.55316434 |
| 89 | PTK6 | 0.55279223 |
| 90 | MAP2K2 | 0.54897950 |
| 91 | PLK2 | 0.53328308 |
| 92 | MAPK4 | 0.53069974 |
| 93 | MAP3K7 | 0.52868279 |
| 94 | ACVR1B | 0.52759727 |
| 95 | STK3 | 0.51568377 |
| 96 | PRKD1 | 0.50431749 |
| 97 | MUSK | 0.49859032 |
| 98 | NEK1 | 0.49655287 |
| 99 | ROCK2 | 0.49639540 |
| 100 | PAK1 | 0.46538411 |
| 101 | PRKG1 | 0.44425721 |
| 102 | EIF2AK1 | 0.44133555 |
| 103 | WNK3 | 0.43166232 |
| 104 | RPS6KA4 | 0.41589933 |
| 105 | PINK1 | 0.41550105 |
| 106 | ILK | 0.40830549 |
| 107 | FGFR4 | 0.40786533 |
| 108 | PRKCH | 0.39881038 |
| 109 | ADRBK1 | 0.39212912 |
| 110 | PRKD3 | 0.39001202 |
| 111 | MARK2 | 0.38995524 |
| 112 | PHKG2 | 0.37659237 |
| 113 | PHKG1 | 0.37659237 |
| 114 | SGK2 | 0.37359121 |
| 115 | BCKDK | 0.36887114 |
| 116 | TAOK1 | 0.36469389 |
| 117 | CAMK2A | 0.35586625 |
| 118 | CAMK2B | 0.35435569 |
| 119 | PKN2 | 0.34885363 |
| 120 | BMX | 0.33304600 |
| 121 | PKN1 | 0.33057004 |
| 122 | MAPKAPK5 | 0.32334315 |
| 123 | MAP3K8 | 0.31925425 |
| 124 | PRKCA | 0.31749926 |
| 125 | GSK3A | 0.31218547 |
| 126 | MTOR | 0.29940200 |
| 127 | DMPK | 0.29807534 |
| 128 | CDK5 | 0.29743847 |
| 129 | GRK1 | 0.29345859 |
| 130 | PRKCZ | 0.29083457 |
| 131 | DAPK3 | 0.28330520 |
| 132 | MINK1 | 0.27123754 |
| 133 | CDK14 | 0.25177611 |
| 134 | MAP3K5 | 0.24747952 |
| 135 | BRAF | 0.23066264 |
| 136 | BUB1 | 0.22359431 |
| 137 | FGFR1 | 0.21801737 |
| 138 | IGF1R | 0.21670471 |
| 139 | MAPK7 | 0.21625732 |
| 140 | INSR | 0.20706695 |
| 141 | EGFR | 0.20637623 |
| 142 | MARK3 | 0.20583032 |
| 143 | SRC | 0.19804991 |
| 144 | BCR | 0.18809394 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.99797654 |
| 2 | Focal adhesion_Homo sapiens_hsa04510 | 2.92258213 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.85228229 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.62953426 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.58825353 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.41569337 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.38858465 |
| 8 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.33791578 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.33736269 |
| 10 | Malaria_Homo sapiens_hsa05144 | 2.27783195 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.24090883 |
| 12 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.20126729 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.05359501 |
| 14 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.04834552 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.01269968 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.96631455 |
| 17 | Adherens junction_Homo sapiens_hsa04520 | 1.93625363 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.91777487 |
| 19 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.80552752 |
| 20 | Amoebiasis_Homo sapiens_hsa05146 | 1.76939616 |
| 21 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.73544916 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72779399 |
| 23 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71841702 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.70921704 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69295417 |
| 26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.68364242 |
| 27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.67219870 |
| 28 | Tight junction_Homo sapiens_hsa04530 | 1.65715224 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.64877376 |
| 30 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.64006409 |
| 31 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.58472609 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.57157619 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52269790 |
| 34 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.47436464 |
| 35 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.46996265 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.42064697 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40991552 |
| 38 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.37878487 |
| 39 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.37257183 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.34227786 |
| 41 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.26954494 |
| 42 | Bladder cancer_Homo sapiens_hsa05219 | 1.24822885 |
| 43 | Shigellosis_Homo sapiens_hsa05131 | 1.24184012 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.23773891 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23043925 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.21217147 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21033512 |
| 48 | Bile secretion_Homo sapiens_hsa04976 | 1.20257455 |
| 49 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.18842070 |
| 50 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.16850005 |
| 51 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.16243047 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16047142 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.15311115 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 1.15254974 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14641762 |
| 56 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.10364686 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.09973561 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09508038 |
| 59 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.04482863 |
| 60 | Mineral absorption_Homo sapiens_hsa04978 | 1.04332964 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.03653488 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.02081821 |
| 63 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.00246475 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99100650 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97049338 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97007620 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96749563 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.94934071 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94209899 |
| 70 | Peroxisome_Homo sapiens_hsa04146 | 0.93664795 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93003164 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91458297 |
| 73 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90727741 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88345328 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88299182 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86514971 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86378298 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.84674155 |
| 79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82833256 |
| 80 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82512851 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.80026227 |
| 82 | Gap junction_Homo sapiens_hsa04540 | 0.77237923 |
| 83 | Melanoma_Homo sapiens_hsa05218 | 0.75704962 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74551560 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.74542449 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74215122 |
| 87 | Viral myocarditis_Homo sapiens_hsa05416 | 0.72667700 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68851053 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.67719795 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.67108446 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.66934631 |
| 92 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66647425 |
| 93 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.66532113 |
| 94 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66505014 |
| 95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66253717 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.64507668 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64211764 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63991771 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63341752 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62800804 |
| 101 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62788769 |
| 102 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.62560682 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61990345 |
| 104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59484125 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57779455 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57489356 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.57389944 |
| 108 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57177466 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56269778 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55618883 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.55211432 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53770292 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.53603975 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51989498 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.51757509 |
| 116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51725361 |
| 117 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51033887 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.50498424 |
| 119 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50239436 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49935869 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.49641666 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49210547 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49098787 |
| 124 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48328139 |
| 125 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47943203 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.46944190 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.46471427 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46156039 |
| 129 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.45548231 |
| 130 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.45514827 |
| 131 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42972833 |
| 132 | Cocaine addiction_Homo sapiens_hsa05030 | 0.42206927 |
| 133 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41383919 |
| 134 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41132215 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.39200961 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37826279 |
| 137 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37670748 |
| 138 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37127745 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37002713 |
| 140 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36866799 |
| 141 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.36611641 |
| 142 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.36348604 |
| 143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36033238 |
| 144 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35921685 |
| 145 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35797247 |
| 146 | ABC transporters_Homo sapiens_hsa02010 | 0.35591020 |
| 147 | Metabolic pathways_Homo sapiens_hsa01100 | 0.33265674 |
| 148 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.32810367 |
| 149 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32590355 |
| 150 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32128383 |
| 151 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28160828 |

